Lazard Ltd. (LAZ) Tops Q4 EPS by 4c

Lazard Ltd. (NYSE: LAZ) reported Q4 EPS of $0.92, $0.04 better than the analyst estimate of $0.88. Revenue for the quarter came in at $593.2 million versus the consensus estimate of $574.92 million.

For earnings history and earnings-related data on Lazard Ltd. (LAZ) click here.

You May Also Be Interested In

• Lazard AUM rises to $286.9 billion at end of July 2026
• Tenon Medical (TNON) Misses Q2 EPS by 395c
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c